These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6278660

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between growth rate and loss of histamine-sensitizing factor during antigenic modulation in Bordetella pertussis.
    Idigbe EO.
    Microbios; 1987; 49(199):79-89. PubMed ID: 2883559
    [Abstract] [Full Text] [Related]

  • 5. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
    Smirnov VD, Chuprinina RP, Siundiukova RA, Maksiutov RV.
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
    [Abstract] [Full Text] [Related]

  • 6. Histamine-sensitizing factor of Alcaligenes faecalis.
    Simmons DG, Rose LP, McCorkle FM, Luginbuhl GH.
    Avian Dis; 1983 Mar; 27(1):171-7. PubMed ID: 6682654
    [Abstract] [Full Text] [Related]

  • 7. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE, Broderick EJ, Levine L.
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer.
    Ben-Nun A, Mendel I, Kerlero de Rosbo N.
    Proc Assoc Am Physicians; 1997 Mar; 109(2):120-5. PubMed ID: 9069580
    [Abstract] [Full Text] [Related]

  • 16. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN.
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [Abstract] [Full Text] [Related]

  • 17. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A, Hawkins DC.
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [Abstract] [Full Text] [Related]

  • 18. [Immunobiological properties of Bordetella pertussis].
    Kopacka B.
    Pediatr Pol; 1972 Feb; 47(3):361-70. PubMed ID: 4336329
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.